Skip to main content

Animations

MJFF Publications

5601 - 5625 of 6514 Results
Title
Year
  • Year
  • 2022
  • 2025
  • 2023
  • 2021
  • 2021
  • 2021
  • 2022
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2021
  • 2025
  • 2009
  • 2023
  • 2009
  • 2023
  • 2022
  • 2009
  • 2008
  • 2003
  • 2020
  • 2013
  • 2016
  • Summary Details
    OPEN
    Title: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older persons
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12255
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-025-03833-1
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00497-x
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Vesicular dysfunction and pathways to neurodegeneration
    Journal Name: Essays in Biochemistry
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1042/ebc20210034
    Citation Count: 13
  • Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology
    2021
    Summary Details
    OPEN
    Title: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12728
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Remote smartphone monitoring of Parkinson’s disease and individual response to therapy
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41587-021-00974-9
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-022-00643-4
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Mutation of the ALS-/FTD-Associated RNA-Binding Protein FUS Affects Axonal Development
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa, cc-by-nc-sa, cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1523/jneurosci.2148-23.2024
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.98775
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A Novel MAG Variant Causes Hereditary Spastic Paraplegia in a Consanguineous Pakistani Family
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/genes15091203
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.96699
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.96699.3
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Open science takes on Parkinson’s disease
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.66546
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adt2050
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1242/dmm.004267
    Citation Count: 175
  • Summary Details
    OPEN
    Title: From policy to practice: Lessons learned from an open science funding initiative
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1011626
    Citation Count: 4
  • Summary Details
    OPEN
    Title: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.300
    Best OA location URL: http://doi.org/10.1038/ng.300
    Citation Count: 536
  • Summary Details
    OPEN
    Title: LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adh9543
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Use of Glycolysis‐Enhancing Drugs and Risk of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29184
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Rapid selection of cyclic peptides that reduce α-synuclein toxicity in yeast and animal models
    Journal Name: Nature Chemical Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nchembio.193
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci35781
    Citation Count: 195
  • Summary Details
    OPEN
    Title: Pitx3 is required for development of substantia nigra dopaminergic neurons
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0230529100
    Citation Count: 387
  • Summary Details
    OPEN
    Title: KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa304
    Citation Count: 107
  • Summary Details
    OPEN
    Title: The Sac1 Domain of SYNJ 1 Identified Mutated in a Family with Early‐Onset Progressive P arkinsonism with Generalized Seizures
    Journal Name: Human Mutation
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa, unspecified-oa
    DOI - Digital Object Identifier: 10.1002/humu.22372
    Citation Count: 337
  • Summary Details
    OPEN
    Title: Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/aww180
    Citation Count: 82
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.